NCT05493839 is a clinical trial in Ards, sponsored by Southeast University, China.

Who is sponsoring NCT05493839?

NCT05493839 is sponsored by Southeast University, China.

Is NCT05493839 still recruiting?

NCT05493839 is currently status unknown. Last updated 9 August 2022.

Last reviewed 2022-08-09 · How we verify

NCT05493839

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Reverification of the Berlin Definition Plateau Criteria in Golmud

Status unknown Last updated 9 August 2022

What this trial tests

trial in Ards in 160 participants. Status unknown.

Timeline

20 June 2022

Primary endpoint
8 August 2022

30 August 2022

Quick facts

Lead sponsor	Southeast University, China
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	160
Start date	20 June 2022
Primary completion	8 August 2022
Estimated completion	30 August 2022
Sites	1 location across China

Conditions studied

Ards — all drugs for Ards →

Sponsor

Southeast University, China

Who can join

Adults 18 to 80, any sex, with Ards. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single-center retrospective study. According to the Berlin diagnostic standard, ARDS patients admitted to the Department of severe Medicine, Golmud People's Hospital from January 2015 to june 2022 were divided into three groups: mild (142mmHg \< PaO2/ FiO2 ≤ 213 mmHg), moderate (71mmHg \< PaO2/ FiO2 ≤ 142mmHg) and severe (PaO2/ FiO2 ≤ 71 mmHg). The ICU mortality, 28-day mortality, non-ventilator time in ICU, ICU hospitalization time observed respectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ards

Currently open trials in the same condition.

NCT07100860 — The Effect of Single Lung Ventilation Duration on Postoperative Pulmonary Complications in Thoracic Surgery · recruiting
NCT06513299 — Effectiveness of Low Volume and Low Pressure in Severe Hypoxemic Patients · active not recruiting

Other Southeast University, China trials

Trials by the same sponsor.

NCT07519512 — Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients · NA · recruiting
NCT06990477 — Effect of EIT-guided PEEP in ARDS Patients With Higher Recruitability · NA · recruiting
NCT07362537 — Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS · NA · recruiting
NCT07327268 — Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS · not yet recruiting
NCT07284888 — Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry- · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05493839 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Southeast University, China
Last refreshed: 9 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing